uBiome to Present at the 36th Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO (PRWEB) January 05, 2018

uBiome will participate in the 36th Annual JP Morgan Healthcare Conference on Monday, Jan. 8th at the St. Regis Hotel San Francisco. Dr. Jessica Richman, co-founder and CEO of uBiome, will present in a session scheduled for 1:45 p.m. PST / 4:45 p.m. EST.

The 90-minute event will be moderated by journalist David Ewing Duncan and will commence with a keynote address from Aetna Health CEO, Jonathan Bush. Dr. Richman will be joined by Dr. Michael Nova, chief innovation officer at Pathway Genomics. The panel discussion will focus on the challenges of data generation and collection as well as the opportunities to apply it and integrate it into daily life.

Dr. Richman and the uBiome executive team will also host a private reception at the Warwick Hotel at 4:30 p.m. PST following the panel discussion.

About uBiome

Founded in 2012, uBiome is the world's leading microbial genomics company with a mission to explore important research questions about the microbiome and develop reliable, accurate products and services, focused on the microbiome. uBiome is funded by Y Combinator, Andreessen Horowitz, 8VC and other leading investors. uBiome's mission is to transform the science of the microbiome into useful products and services that improve people's lives.

Press Contacts
Lelle Henrichsen
lelle.henrichsen(at)ubiome.com

Mary Lewis
mary.lewis(at)ubiome.com

Investor Contact
Jessica Richman, PhD
jessica(at)ubiome.com

Read the full story at http://www.prweb.com/releases/2018/01/prweb15059074.htm

You May Also Be Interested In

• Sisecam’s $1.1 Billion Eurobond Issues Receive Over $3.5 Billion in Demand
• FCA Packaging Invests in Greentree Packaging and Lumber
• Rugged Tablet Market to Reach USD 1.33 Billion by 2031 Driven by Growing Demand from Industrial and Defence Sectors